Clinical Trial Update: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety results for CD07805/47 topical gel in facial erythema associated with rosacea have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• CD07805/47 Topical Gel (CD07805/47 topical gel)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2013-11-21